Stefania Roberts
Overview
Explore the profile of Stefania Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin F, Roberts S, Magnusson M
Aesthet Surg J Open Forum
. 2025 Feb;
7:ojae120.
PMID: 40008214
Background: Paradoxical masseter bulge (PMB) is an uncommon complication following treatment with botulinum neurotoxin-A (BoNT-A). This is currently believed to be caused by the uneven distribution of BoNT-A within the...
2.
Guidelines for management of actual or suspected inadvertent intra-arterial injection of sclerosants
Parsi K, De Maeseneer M, van Rij A, Rogan C, Bonython W, Devereux J, et al.
Phlebology
. 2024 Jul;
39(10):683-719.
PMID: 39046331
Background: Inadvertent intra-arterial injection of sclerosants is an uncommon adverse event of both ultrasound-guided and direct vision sclerotherapy. This complication can result in significant tissue or limb loss and significant...
3.
Currie E, Granata B, Goodman G, Rudd A, Wallace K, Rivkin A, et al.
Aesthet Surg J
. 2024 Jan;
44(6):647-657.
PMID: 38262634
Background: Hyaluronic acids (HAs) continue to be the fillers of choice worldwide and their popularity is growing. Adverse events (AEs) are able to be resolved through the use of hyaluronidase...
4.
Goodman G, Roberts S, Cook N, Ashton M, Nie R, Alker L, et al.
J Drugs Dermatol
. 2024 Jan;
23(1):1325-1331.
PMID: 38206149
Background: A phase 4, prospective, open-label, multicenter study showed that treatment with deoxycholic acid injections (ATX-10) followed by a hyaluronic acid filler (VYC-20L) is safe and effective for reducing submental...
5.
Nguyen J, Roberts S, Lee A
Phlebology
. 2023 Feb;
38(5):352-353.
PMID: 36853983
No abstract available.
6.
Goodman G, McDonald C, Lim A, Porter C, Deva A, Magnusson M, et al.
Aesthet Surg J
. 2023 Feb;
43(6):NP438-NP448.
PMID: 36759325
Background: The pathogenesis of delayed-onset tissue nodules (DTNs) due to hyaluronic acid (HA) injections is uncertain. Objectives: To formulate a rational theory for DTN development and their avoidance and treatment....
7.
Master M, Roberts S
Plast Reconstr Surg Glob Open
. 2022 Apr;
10(4):e4252.
PMID: 35433153
We present a case report of hyaluronic acid (HA) injected in the subcutaneous fat of the lateral face, deep fat compartments of the mid-face, and a combination of deep and...
8.
Lin F, Goodman G, Magnusson M, Callan P, Roberts S, Hart S, et al.
Aesthet Surg J
. 2022 Mar;
42(10):1109-1116.
PMID: 35348575
Background: Aspiration prior to hyaluronic acid filler injection is often taught as a safety maneuver to minimize the risk of intravascular injection; however, the validity of this technique in aesthetic...
9.
Goodman G, Magnusson M, Callan P, Roberts S, Hart S, Lin F, et al.
Aesthet Surg J
. 2021 Jan;
42(1):89-101.
PMID: 33512439
Background: Aesthetic physicians rely on certain anecdotal beliefs regarding the safe practice of filler injections. These include a presumed safety advantage of bolus injection after a negative aspiration. Objectives: The...
10.
Goodman G, Magnusson M, Callan P, Roberts S, Hart S, McDonald C, et al.
Aesthet Surg J
. 2020 Nov;
41(4):NP134-NP136.
PMID: 33236760
No abstract available.